Abbott agreed to pay $46.75 in cash and 0.8708 shares of its common stock for every share of St. Jude Medical. Taken together, the deal equals about $85 per share of St. Jude stock, reflecting a 37% premium on Wednesday's closing price of $61.97.
Julian Emanuel, U.S. equity and derivatives strategist at UBS, and Gary Shilling, president at A. Gary Shilling & Co., discuss Abbott Laboratories' agreement to buy St, Jude Medical Inc.
Abbott Laboratories to buy St. Jude Medical for $25 billion
Medical device manufacturer Abbott Laboratories has reached a deal to acquire fellow medical device maker St. Jude Medical in a cash-and-stock deal valued at $25 billion.